Sartorius AG
SOAGY
Rank in Stocks
#1259
Sartorius AG, founded in Göttingen, Germany in 1870, is a global supplier of... Sartorius AG, founded in Göttingen, Germany in 1870, is a global supplier of advanced bioprocess solutions, laboratory products, and associated services. The company's diverse portfolio encompasses several critical areas: For biosensing and detection, it provides biosensors, compliance instruments, system software, label-free detection technologies, and SPR systems. In cell analysis, Sartorius offers live-cell analysis platforms, flow cytometry systems, and specialized cell analysis reagents and consumables. Its media and reagent segment includes a wide array of formulations for antibody and recombinant protein production, viral vaccines, regenerative medicine, and stem cell cultivation, along with downstream buffers, microcarriers, strong acids, bases, alcohols, and detergents. The company manufactures various bioreactor systems, from multi-parallel and benchtop units to single-use, stainless steel, cell culture, and microbial bioreactors, all supported by dedicated software applications. Its extensive filtration product line features membranes, blotting products, filter papers, and glass and quartz microfibre products, alongside a comprehensive range of filtration devices for ultrafiltration, sterile filtration, harvesting, analytical and diagnostic sample preparation, particle analysis, pharmaceutical applications, protein/DNA concentration, venting, clarification, and membrane chromatography. Sartorius also delivers solutions for process filtration, process chromatography, fluid management, and cutting-edge process analytical technology with data analytics. Complementary laboratory equipment includes industrial microbiology systems, water purification units, precision weighing and pipetting/dispensing systems, OEM components, and centrifuges. Beyond its products, Sartorius provides essential services such as bioprocess development and engineering, protein expression system optimization, media and process development, comprehensive testing, instrument support, and validation. These offerings primarily serve the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industrial sectors across the globe.
Share Price
$66.15
Last synced: 2026-11-09
Market Cap
$17.75B
Change (1 day)
2.43%
Change (1 year)
22.39%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Sartorius AG (SOAGY)
Category
Healthcare
EPS for Sartorius AG (SOAGY)
EPS as of September 2026 TTM: $0.70
According to Sartorius AG's latest financial reports, its current EPS (TTM) is $0.70. At the end of 2025 the company had an EPS of $0.50, an increase over its 2024 EPS of $0.25.
EPS history for Sartorius AG from 2002 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.70 | 40.52% |
| 2025 | $0.50 | 102.04% |
| 2024 | $0.25 | -62.35% |
| 2023 | $0.66 | -76.84% |
| 2022 | $2.86 | 101.49% |
| 2021 | $1.42 | 24.16% |
| 2020 | $1.14 | 59.42% |
| 2019 | $0.72 | 52.40% |
| 2018 | $0.47 | 18.99% |
| 2017 | $0.40 | 25.44% |
| 2016 | $0.32 | -21.43% |
| 2015 | $0.40 | 137.19% |
| 2014 | $0.17 | -17.89% |
| 2013 | $0.21 | 11.69% |
| 2012 | $0.18 | 18.93% |
| 2011 | $0.16 | 26.26% |
| 2010 | $0.12 | -490.48% |
| 2009 | $-0.03 | -162.75% |
| 2008 | $0.05 | -60.96% |
| 2007 | $0.13 | 13.60% |
| 2006 | $0.11 | 45.13% |
| 2005 | $0.08 | 30.65% |
| 2004 | $0.06 | 264.02% |
| 2003 | $0.02 | 35.54% |
| 2002 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | 1,091.29% |
US
|
|
| $6.02 | 757.09% |
FR
|
|
| $4.15 | 490.66% |
US
|
|
| $5.32 | 657.20% |
JP
|
|
| $0.67 | -4.64% |
US
|
Questions about Sartorius AG's earnings per share (EPS)
What is Sartorius AG's earnings per share (EPS)?
Sartorius AG's earnings per share (EPS) over the last twelve months is $0.70, as of Sep 2026.
What was Sartorius AG's earnings per share (EPS) in 2025?
In 2025, Sartorius AG's earnings per share (EPS) was $0.50, 100.00% more than in 2024 ($0.25).
How has Sartorius AG's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Sartorius AG's earnings per share (EPS) went from $1.14 to $0.50, an average decline of 15.20% a year.
How does Sartorius AG's earnings per share (EPS) compare with similar companies?
Sartorius AG's earnings per share (EPS) ($0.70) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.